MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.20 +0.15 (4.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $2.51 | |||
| Open | $3.03 | 52 Week Low | $0.41 | |||
| Day High | $3.21 | P/E | N/A | |||
| Day Low | $3.01 | EPS | $-0.64 | |||
| Volume | 3,254,700 | |||||
